177
Participants
Start Date
September 25, 2018
Primary Completion Date
August 17, 2023
Study Completion Date
December 31, 2024
BMX-001
BMX-001 consists of a porphyrin ring with pyridyl groups attached at each of the four methane bridge carbons. The nitrogen in the pyridyl ring is at the 2 position and has a side chain consisting of six carbons with an ether linkage. A manganese atom is chelated into the porphyrin ring and is the active center of the molecule. This molecule is an enzymatic scavenger of free radical species operating at close to diffusion-limited rates.
Radiation Therapy
RT will be delivered in daily fractions of 1.8-2 Gy given 5 days a week for 6 weeks for a total of 59.4-60 Gy.
Temozolomide
Initially, temozolomide (TMZ) will be dosed at 75 mg/m2 orally daily for 42 days. Two weeks after the completion of chemoradiation, patients will transition to adjuvant chemotherapy with TMZ dosed at 150-200 mg/m2 orally for 5 days of a 28-day cycle for a total of 12 cycles.
Duke Cancer Institute, Durham
University of Alabama- Birmingham, Birmingham
University of Kentucky, Lexington
Ohio State University, Columbus
St. Luke's Hospital, Kansas City
University of Nebraska Medical Center, Omaha
Huntsman Cancer Institute, Salt Lake City
University of California San Francisco, San Francisco
University of Washington, Seattle
Lead Sponsor
Duke Cancer Institute
OTHER
National Cancer Institute (NCI)
NIH
BioMimetix JV, LLC
INDUSTRY